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Abstract 
A DNA-based assay for the detection of one-point mutation in TP53 gene, 
responsible for lung cancer, was developed using a surface plasmon resonance 
(SPR) and a quartz crystal microbalance (QCM) biosensor systems. Amine coupling 
was employed for the immobilization of NeutrAvidin on thiol- derivatised surface to 
capture the biotinylated target sequence. Two targets sequences and one control 
DNA sequence were investigated including, a fully complementary (30 mer), one-
point mutation and a non-complimentary DNA using hybridization with a detection 
probe strand (27 mer). The most appropriate surface coating was also examined for 
both sensor platforms with hybridization and single nucleotide polymorphism (SNP) 
detection efficiency were then compare. A 0.03 - 2 µM concentration range of 
detection probe was detected using the SPR and QCM sensors on wild and mutant 
type target surfaces. The linear regression analysis was performed for both sensors 
resulting in a R2 value for the SPR assay of 0.985 and 0.993 for perfect and 
mismatch reaction and of 0.978 and 0.976 for the QCM assay, respectively. The 
obtained results demonstrate that the used approach represents a very promising 
future method for the detection of one-point mutation in genetic-based health 
problem with highly sensitive, specific, and real-time analysis. 
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1. Introduction 
The human genome is subjected to mutations during the lifecycle due to several 
types of change in the DNA. The mutation may arise from viruses, radiation, 
transposons, mutagenic chemical or any errors that occur during DNA replication or 
meiosis process in the cell [1, 2]. Many mutations have no effect on phenotype or 
health whereas some mutations cause crucial diseases such as cancer or cardiac 
diseases and  therefore, better understanding of mutation effects on phenotype is 
very important part of genetic studies [3,4]. Various methodologies have been 
currently employed for the detection of mutation in cancer cases and TP53 gene is 
one of the most investigated genes due to its relation with many types of human 
cancers and cells pathways [5]. Most regions of this gene have been investigated 
using PCR-based techniques [6], sequencing with microarray technology [7], and 
fluorescence-based techniques [8].  
As a strong alternative to the above techniques, biosensor technology has 
recently constituted a real-time, label-free, sensitive and rapid approach to be used 
for DNA mutation detection. Various types of sensors have been employed for 
hybridization assay studies including electrochemical, optical and piezoelectric based 
sensors showing high efficiency [9-11].  
A wide range of investigations  have been conducted  regarding p53 gene 
mutations in cancer cases; most of these are genetic or medicine-based studies 
where the detection of mutations have been mainly achieved using common 
traditional  techniques and tools. Biosensor technologies through novel approaches 
provides a strong alternative to generally used methodologies for the detection of 
hereditary diseases; moreover, the technology constitutes a promising future 
methods of testing  in hospitals due to the real-time, rapid and highly specific nature 
of biosensors [12-14]. However, to obtain a sensitive and highly specific detection 
method for cancer markers, development of sensor platforms and surfaces are the 
crucial points in this research field. Both protein and gene markers for many diseases 
have been studied with biosensor technologies [15-19]. Though there have been very 
limited published research on SNP detection, the published data for cancer diagnosis 
has recently shown a rapid increase [20-23]. Most published research in this area 
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use commercially available nucleotide products and show a promising approach for 
the detection of gene-related diseases in human patient samples. 
In the present study, SPR based sensor chip (Biacore 3000) and a new QCM-
based sensors (QCMA-1, Sierra Sensors) were employed to develop a hybridization 
and SNP detection assay for the detection of TP53 mutations. Due to the importance 
of the surface chemistry used on sensor surface and its role in increasing the 
capacity of biomarker detection, a surface selection procedure was initially performed 
on the SPR bare gold sensor chip and the surface with the best output for both 
single-strand DNA probe capture and DNA hybridization assays was then selected 
for use for both the SPR and QCM assay development [24].  A 1% MUDA (1% 2 mM 
MUDA and 99% 2 mM MUDO) coated sensor surface with an immobilized 
NeutrAvidin using EDC/NHS chemistry was therefore used in this study. After 
obtaining prospective success from the SPR biosensor for SNP detection, the same 
procedure was then transferred to a QCM-based sensor platform.  However,  the 1% 
MUDA coated QCM sensor surface did not give good results and hence three other 
different ethanolic solution of MUDA were examined  and the highest response was 
achieved by coating of the surface with 100% MUDA (2 mM MUDA, MUDO free). 
Through two separate sensor platforms, SNP detection in codon 248 of p53 gene for 
lung cancer diagnosis was researched using commercially available oligonucleotides. 
The mutation in codon 248 and 273 shows the commonest frequency for all lung 
cancer cases. An efficient DNA capture and hybridization were initially obtained and 
then SNP detection was examined via both sensor types. 
 
2. Experimental 
2.1. Reagents 
Mercaptoundecanoic acid (MUDA), mercaptoundecanol (MUDO),  
spectrophotometric grade ethanol, phosphate buffered saline (PBS, 0.01 M 
phosphate buffer, 0.0027 M potassium chloride and 0.137 M sodium chloride, pH 
7.4), and all oligonucleotides were purchased from Sigma-Aldrich (Poole, UK). 1-
ethyl-3-(3-dimethylaminopropyl)-carbodiimide (EDC) and NeutrAvidin (NA) and EZ-
link-sulfo-NHS-Biotin were purchased from Pierce-Thermo Scientific (Cramblington, 
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UK). Oxygen free nitrogen was purchased from BOC (Manchester, UK). Ultrapure 
water (18 MΩ cm−1) was obtained from a Milli-Q water system (Millipore Corp., 
Tokyo, Japan). Tris-HCI, NaCI, EDTA and Tween 20 were purchased from Sigma- 
Aldrich (Poole, UK).  
 
Oligonucleotides were bought from Sigma-Genosis (Poole, UK).  The used 
oligonucleotides sequences; Wild-type target: 5’ [Biotin] 
CAGCTTTGAGGTGAGTGTTTGTGCCTGTCC, mutant-type target: 5’ [Biotin] 
CAGCTTTGAGGTGATTGTTTGTGCCTGTCC, scrambled DNA sequence: 5’ [Biotin] 
CCATCGGCATGTACCGTATCGGCGCGT, detection probe: 5’ [Biotin] 
GGACAGGCACAAACA ATCACCTCAAAG. Here the detection probe was selected 
with biotin for possible inclusion of an amplification step, however, a probe without 
biotin should otherwise be used in the assay. 
 
 
2.2. Instrumentations 
A Biacore 3000 instrument with bare gold sensor chips (Biacore, GE Healthcare, 
Uppsala, Sweden) and a fully automated QCMA-1 system with bare gold sensor 
chips (Sierra Sensors GmbH, Hamburg, Germany) were used in this study.  Biacore 
sensor has four sensing spots whilst QCMA-1 has two sensing spots.  The operating 
temperature of the assays was 20ºC and the flow rate of the buffer was 10 μl min-1 
for the Biacore 3000 whereas for the QCMA-1 a 25 ºC and 80 μl min-1 were used 
throughout the assay. Three sensing spot of the Biacore 3000 sensor platform were 
used; each of wild-type, mutant-type and scrambled DNA sequences were injected to 
the separate sensing spot to perform simultaneous assay on both target and control 
surfaces. On the other hand, since QCMA-1 has only 2 sensing spot, one of the 
spots  was always used as control surface through injecting scrambled DNA surface 
on the spot whereas another spot was employed for either wild-type target or mutant-
type target in separate experiments.  
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2.3. Procedures 
2.3.1 Sensor surface preparation  
The SPR sensor chip surfaces of the Biacore 3000 instrument were prepared by 
immobilising NeutrAvidin on separate three sensing spots. The immobilisation of 
NeutrAvidin was obtained using conventional amine coupling chemistry, simply 
named as EDC/NHS chemistry and previously degassed PBS was used as running 
buffer during the immobilisation process of NeutrAvidin. First, the sensor chips were 
coated with the mixture of MUDA and MUDO to obtain a self assembled monolayer 
(SAM) on the bare gold sensor surface. Both thiol solutions were prepared in pure 
ethanol as 2 mM stocks and 1% MUDA (1% 2 mM MUDA and 99% 2 mM MUDO) 
was then prepared using these stock solutions. To immobilize NeutrAvidin, the SAM 
coated sensor chip was docked to the Biacore instrument and then the instrument 
was primed with PBS running buffer. After priming, the sensor chip surface was 
initially cleaned by a mixed solution of 1% Triton and 100 mM NaOH through injection 
of this solution to the sensing spots for 1 minute to prevent from any particles on the 
surface prior to activation of MUDA coated surface with EDC/NHS. Sensor surfaces 
were activated with a 1:1 mixture of 400 mM EDC and 100 mM NHS that previously 
prepared and stocked at -20 °C, and mixed immediately before the experiments. The 
mixed solution of EDC/NHS was injected to the three sensor surfaces for 3 min. A 
100 µg ml-1  NeutrAvidin (diluted in 1 X PBS buffer) was then injected to the surfaces 
for two times as 5 and 3 minutes to immobilize NeutrAvidin on surfaces. At the end of 
immobilization, 1M ethanolamine (pH: 8.5) was injected to the sensor chip surface 
during 3 minutes for blocking non-reacted NHS esters to prevent from non-specific 
bindings. 
 
The QCM bare gold chips were firstly coated with 100% MUDA solution (2 mM 
MUDA; MUDO free) during overnight incubation under dark condition at room 
temperature after cleaning of the QCMA-1 chips by nitrogen plasma. The coated 
chips were then docked to the QCMA-1 instrument and dH2O was changed to PBS 
buffer for priming and then immobilization of NeutrAvidin. The surfaces of the chips 
were firstly washed with a mix solution of Triton and NaOH by injection of the solution 
for 1 minute. EDC/NHS was then injected to the two separate sensing spots of the 
instrument to activate the surface. A 5 minutes injection of 100 µg ml-1 NeutrAvidin 
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was then performed and 1M ethanolamine was then used to cap non-reacted NHS 
esters on the surface during 3 minutes to complete the immobilisation step of the 
assay. Degassed PBS was used as running buffer during the immobilisation period. 
 
2.3.2 DNA capture and hybridization assays for SNP detection  
Three different surface sequences (wild-type target, mutant-type target and 
scrambled DNA Sequence) for DNA capture and one detection probe for 
hybridization were used. Wild-type target included the region of p53 gene which is 
responsible for codon 248 and mutant-type target had the same DNA sequence of 
the wild-type target except for a particular base that converse from G to T when a 
SNP occurs due to lung cancer. Scrambled surface had a completely different 
oligonucleotide sequence from other target sequences and it was used to obtain a 
control surface for hybridization reaction, since the detection probe was not 
complementary for this surface probe.  
 
Moreover, detection probe was designed according to the sequence of mutant-
type target that means it shows a perfect match with mutated sequence whereas it 
has a mismatch on wild-type target due to one nucleotide change. Therefore, the 
expected results from the hybridization reaction should be higher on the mutant-type 
target than the wild type and the obtained hybridization on the scrambled sequence 
would be at approximately zero level.  The principle of SNP detection according to 
the used design in this study is represented in Fig.1. After NeutrAvidin immobilization, 
running buffer was changed from PBS to Tris-Tween (10 mM Tris-HCI, 1 mM EDTA, 
150 mM NaCI, 2.5 ml 0.05% Tween 20, pH: 7.0) for DNA capture and hybridization 
assay. Tris-Tween buffer was degassed and used as a running and dilution buffer. 
With changing PBS to Tris-Tween running buffer, the Biacore 3000 instrument was 
primed and then single-stranded surface sequences (wild-type target, mutant-type 
target and scrambled control) were injected to the separate sensing spots of the 
sensor using a 50 µM concentration in all experiments  and each  was injected to the 
particular sensing spots for 5 minutes and the RU changes were recorded during this 
period. After injection of all capture sequences and the immobilisation was 
completed, biotin blocking solution (pH: 7.6, 11.5 mg was diluted in 50 ml as a stock 
solution) and was injected to the sensor spots for 1 minute  to cap sequence-free 
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NeutrAvidin molecules on the sensor surface and to prevent  non-specific binding 
during the hybridization stage of the assay. This proved to be highly efficient in 
capping all unoccupied NeutrAvidin molecules.  The detection probe was then 
injected and the hybridization reaction took place. The concentration series used for 
the detection probe was in the range of 0.03-2 µM in the Biacore 3000 assays. Both 
surface sequences and detection probe were diluted in Tris-Tween buffer and this 
was also used as the running buffer during the capture of surface sequences on 
NeutrAvidin immobilized sensor surface until the completion of the hybridization 
reaction using detection probe. During the serial hybridization reactions, the surface 
was regenerated with 100 mM HCI without loss of activity. Each concentration of 
detection probe was injected to three sensing spots simultaneously for 5 minutes and 
the RU change was recorded during this time. Here, three sensing spots of the SPR 
sensor were only used (one for the wild type target surface , the second for the 
mutant target surface and the third was employed to immobilised the scrambled 
sequence that provided control surface throughout the assays). 
 
A similar method was followed for the DNA capture and hybridization assays 
using the QCMA-1 instrument. However, since QCMA-1 has only two sensing spots, 
one was always used for scrambled sequence capture on the surface to obtain a 
control surface whereas the other spot was used for injection of either mutant-type or 
wild-type targets. To stabilize the experimental conditions to the utmost, target 
surfaces (either wild-type or mutant-type) were injected to first sensing spot of the 
instrument whilst scrambled sequence was injected to the second spot. The injection 
time of each capture sequence was 5 minutes and after the capture of sequences, 
non-capped NeutrAvidin molecules were blocked by 1 minute injection of biotin 
solution (prepared as previously). After the target/control sequence capture of the 
assay completed, hybridization was started with detection probe injection. The same 
concentration range of detection probe was used here as that applied on the SPR 
sensor with the Biacore 3000 instrument and the dilution of the concentration series 
was done using Tris-Tween buffer. After each 5 minutes injection of detection probe 
depending on concentration used, the surface was regenerated with 100 mM HCI 
solution during 1 minute injection.  
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3. Results and discussion 
 
3.1 Development of the SPR assay  
 
The Biacore 3000 instrument was used as the biosensor platform for SNP 
detection. Bare gold surfaces of the SPR sensor chips were coated with 1% MUDA to 
obtain a self assembly monolayer for NeutrAvidin immobilization. The chip was then 
docked to the system and primed with buffer flow. NeutrAvidin was immobilized to the 
surface through conventional EDC/NHS chemistry. The recorded RU change for 
NeutrAvidin immobilization was 3661 ± 701 RU (n=30) (Fig. 2a). Due to adequate 
immobilization level of NeutrAvidin, the assay was followed by target sequence 
capture. A 50 µM concentration of wild-type, mutant-type and scrambled surface 
sequences were injected to separate sensing spots of the instrument for 5 minutes 
(Fig. 2b). Mutant-type and wild-type DNA sequences were employed as target 
surfaces whilst scrambled sequence was used as a control surface to understand the 
specificity of the interaction. Mutant-type target captured sensors produced 525 ± 55 
RU change (n=10), whereas the recorded response for the wild-type and scrambled 
probes were 539 ± 71, 564 ± 45 RU (n=10),respectively (Fig. 2c). The produced RU 
change of the sensor for each capture sequence was similar and this was an 
expected result since all sequences (both target sequences and scrambled 
sequence) had approximately the same nucleotide length. The difference between 
targets and scrambled sequence was slightly higher since the oligonucleotide content 
was completely different. Moreover, %GC content and secondary structure of 
oligonucleotides may affect the binding capacity on the sensor [23]. %GC content of 
wild, mutant and scrambled surface sequences were 56.7, 50 and 63, respectively, 
and the probability of forming secondary structure for targets was weak whereas it 
was at moderate level for scrambled sequence. 
 
With obtaining an adequate signal for the NeutrAvidin immobilization and DNA 
capture from the sensor surfaces, the assays were then followed by conducting the 
hybridization reaction. Detection probe designed according to the mutant-type target 
surface to achieve perfect match was employed in the concentration range of 0.03-2 
µM. The results showed gradual increases in the RU values were achieved when the 
concentration increased from 0.03 µM to 1 µM. However, the obtained RU change 
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after 1 µM concentration of detection probe generally showed a study state response 
(Fig. 3a and b). In order to show the appropriate concentration to be used for 
detection without competition, both 1 µM and 2 µM were used as higher 
concentrations and the shown data in this study represents the overall results of the 
experiments for these concentrations. Hybridization reaction was successfully 
obtained in selected concentration range of detection probe using Biacore 3000 
instrument. Furthermore, non-specific binding on the control surface was recorded at 
zero level whereas a high response was obtained on the target surfaces including the 
wild-type and the mutant-type capture sequences. A clear difference was achieved 
between the two target surfaces in which hybridization on mutant-type capture 
sequence gave higher response as RU change than the wild-type surface due to 
perfect match with the detection probe, whilst the wild-type target had a mismatch 
due to single nucleotide polymorphism (SNP).  
 
The detection of each concentration was continued only for 5 minutes including 
injection of the sample and recording of the RU change.  A complete regeneration of 
the surface for the next binding was carried out using 0.1 M HCI solution. A linear 
increase was observed until a 1 µM concentration of complementary detection probe 
was added. Furthermore, low concentration of hybridization probe (0.03 µM) was 
successfully detected with a clear and specific response produced by the SPR-based 
biosensor platform. Hagihara and colleagues, studied the detection of G-A 
mismatches using an SPR sensor and  showed that a concentration range of 0.13-1 
µM DNA can be  detected using interaction of naphthyrine-azaquinolone hybrid 
molecules on the surface instead of NeutrAvidin-biotin interaction by applying 
EDC/NHS surface chemistry method [25]. Our results using the Biacore 3000 
showed a linear response with R2 values of 0.98 and 0.99 for perfect match on 
mutant-type surface probe and SNP on wild-type surface, respectively (Fig. 3c).  The 
expected output was achieved from this work for SNP detection using the Biacore 
3000 instrument and the sensor surface developed in this study. The use of the 
appropriate surface chemistry and assay method on the sensor chip constitute the 
most critical step for SNP detection [24]. Though a clear hybridization was obtained 
from different type of surfaces, the efficiency of the binding must be very high to 
achieve single-nucleotide polymorphism detection since it requires  higher sensitivity 
than that required for  the detection of a piece of DNA or RNA sequence. 
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3.2 Development of the QCM assays 
Here, a QCMA-1 biosensor system was also used to evaluate the hybridization 
efficiency of oligonucleotides using a QCM-based sensor and to compare results of 
SNP detection with the Biacore 3000 device. Different % concentrations of 2 mM 
MUDA were examined for surface chemistry modification on the QCM sensor 
surface. A 100% MUDA (2 mM MUDA, MUDO free) was found to be the optimal 
concentration to be used for the assay development on the QCM bare gold sensor 
chip.  This enabled a self assembled monolayer to be formed which gave the best 
output for DNA capture on the surface with each single-stranded surface probe (data 
not shown). A 100 µg ml-1 neutravidin was initially immobilized to two separate 
sensing spots of the instrument using EDC/NHS chemistry after the sensor chip 
surface was washed with mixed solution of 1% Triton and 100 mM NaOH during a1 
minute injection. NeutrAvidin immobilized sensors produced an average frequency 
change of 773 ± 95 Hz (n=10). 
 
In each assay, the first spot was used for either wild or mutant-type targetss and 
the second spot was always employed for capture of scrambled sequence as a 
control surface. A 50 µM concentration of each surface sequence was injected to the 
particular sensing spot of the sensor during 5 minutes and DNA sequence-free areas 
of the surface were then blocked by a 1 minute injection of biotin solution to cap the 
free sites on the neutravidin surface. The recorded frequency changes were obtained 
as 233 ± 28 (n=10), 237 ± 27 (n=10) and 220 ± 29 Hz (n=10) for mutant, wild and 
scrambled surfaces respectively (Fig. 4a). The produced frequency values of the 
sensor for the two target surfaces (wild and mutant) were close to each other, with a 
lower frequency achieved for the scrambled surface since the targets had the same 
oligonucleotide sequences except for one base which was G in wild-type target 
instead of T.  
 
The DNA capture assay was followed by hybridization using the detection probe. 
This probe was designed as fully complementary to mutant-type single stranded 
target surface; therefore, a higher response was expected from binding of detection 
probe on the mutant-type target surface than the wild-type on which a mismatch 
existed due to SNP. The studied concentration range of detection probe was 0.03-2 
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µM and a clear decrease was observed after 1 µM because of competition between 
the DNA molecules. The specificity of the assays was very high since the detection 
probe did not bind to the control surface as seen in Fig. 4b.  Each concentration of 
hybridization probe was injected to both sensing spots for 5 minutes and the sensor 
surfaces were regenerated by a 1 minute injection of 0.1 M HCI.  
 
Furthermore, a gradual increase was observed for the hybridization depending on 
the concentration on both wild and mutant-type target surfaces with a high specificity. 
A 0.03 µM concentration of hybridization probe could be detected by QCMA-1 
sensor. The recorded frequency change for 0.03 µM was 26 ± 10 Hz (n=10) whereas 
non-specific binding of the detection probe on the control surface was only 2 ± 1 Hz 
(n=10) (Fig. 4b). 
 
The expected hybridization potential was successfully achieved with a linear 
concentration range of the detection probe on both wild and mutant target surfaces 
with high specificity. This achievement demonstrated that the QCM-based biosensor 
is very suitable for the detection of nucleic acids, particularly for DNA molecules. 
Moreover, the aim of the study was to detect the one-point mutation of lung cancer 
for early diagnosis; thus, all collected data for each target surface was evaluated and 
compared to understand if a difference exists or not between the hybridization of 
detection probe on wild and mutant-type target sequences. According to our design 
for the artificial DNA probe, a higher response was expected from the interaction of 
mutant-type target and detection probes due to the perfect match between the two 
sequences. The overall results show that one-point mutation was clearly detected 
through the QCMA-1 instrument, when concentrations of above 0.5 µM were used. 
The correlation efficient of SNP detection on target surfaces in the linear dynamic 
range of 0.03-2 µM is shown in Fig. 4c. 
 
When the reproducibility and effectiveness of the two sensor platforms were 
compared for SNP detection, the SPR-based biosensor gave better results than the 
QCM-based sensor, though the results obtained from both platforms showed 
similarity. Since the capture of targets on the sensor chip surfaces were stronger in 
the Biacore 3000 than QCMA-1 the obtained responses for hybridization in the 
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sensors was parallel to the amount of target DNA capture on the sensor chip 
surfaces (Fig. 5a and b). 
 
This study has shown a highly promising future for diagnosis of various diseases 
that has genetic marker by biosensor technology. Although there are a number of 
published studies in the literature regarding the detection of nucleotides using SPR-
based sensors, to date the success for SNP detection have been very limited by this 
technology. Jiang et al. used SPR-technology to detect a mutation in the region of 
p53 gene that corresponding to codon 248 [26] and they used previously optimized 
analytical parameters of two different SPR-based sensors developed by Wang et al 
[27]. In addition, a published study about SNP genotyping for increased risk of 
venous thrombo-embolism was performed with an optical sensor in which optical 
thin-film biosensor chips were used and a ligation-based assay was applied on 
optical-detection platform instead of fluorescence-detection methods with a more 
sensitive and rapid approach. However, the method used in our work takes only 5 
minutes for the detection of the target sequence whereas the applied procedure used 
in other work took up to 45 minutes [20].   
Other researchers, such as Nakatani et al [28], developed a method to detect 
SNP using an SPR sensor with a similar procedure when compared with our study. 
However, their mutation analysis was based on the binding between naphthyridine 
and  G-G mismatch. The method detects a single nucleotide mutation from G to C or 
C to G, and uses molecular modelling for  the discovery of low-molecular-weight 
ligands of dimeric naphthyridines 1 and 2 which specifically bind with high affinity to 
the G-G mismatch, irrespective of the sequence flanking the mismatch. Their results 
suggested that the G-G mismatch would be significantly stabilized when two 
naphthyridine intercalators simultaneously bind to both G bases within the base 
stacks of the DNA duplex. They investigated 27-mer DNA duplexes in the 
concentration range of 0.125-1 µM. The work we presented in this paper showed  a 
broader dynamic range of the method we developed for SNP analysis  (0.03-2 µM), 
with lower detection limit which is important for the detection of real patient samples. 
Moreover, there is no need to use specific base-pair mismatch in our study when 
compared to Nakatani et al work [28]. Okumura et al [29], developed a method for a 
K-ras point mutation detection using a sandwich assay enhanced with hydrogel 
nanospheres and surface plasmon resonance imaging technique. In their study, a 
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homobifunctional alkane dithiol was first adsorbed on Au film and ethyleneglycol 
diglycidylether (EGDE) was then reacted to insert the ethyleneglycol moiety, which 
can suppress nonspecific adsorption during SPR analysis.  Streptavidin was then 
immobilized on EGDE using tosyl chloride activation. Biotinylated DNA ligands were 
then bound to the streptavidin modified surface to produce the DNA arrays. In the 
SPR analysis, the DNA analyte was exposed on the DNA array and hybridized with 
the immobilized DNA probes. Subsequently, the hydrogel nanospheres conjugated 
with DNA probes were bound to the DNA analytes in a sandwich configuration which 
led to SPR signal enhancement and enabled the  discrimination of  a K-ras point 
mutation in the SPR difference image. This investigation has shown similar 
procedure with our study in which covalent interaction of the steptavidin-biotin 
molecules was used to produce DNA arrays. However, the researchers used hydogel 
nanosheres to enhance the signal which make their procedure more complex and 
expensive when compared to our method. Dell’Atti et al [30] also investigated TP53 
point mutations using QCM-based sensor. In the study, a DNA-based piezoelectric 
biosensor for the detection of the TP53 gene mutation at codon 248 was reported. A 
biotinylated probe was immobilised on the sensor surface via dextran–streptavidin 
modified surfaces. The sensor was optimised using synthetic oligonucleotides and . 
applied to polymerase chain reaction (PCR)-amplified real samples of DNA extracted 
from two cell lines, one normal (wild-type) and one mutated, carrying the mutation at 
codon 248 of the TP53 gene. The results obtained demonstrate that the DNA-based 
piezoelectric biosensor is able to detect the point mutations in PCR-amplified 
samples showing the potentialities of this approach for routine analysis [30]. The 
method used is similar to our present work. However, we used the specific interaction 
between neutravidin and biotin instead of dextran-streptavidin; and we successfully 
investigated a broader dynamic range of the samples with an excellent specificity and 
sensitivity in both SPR and QCM-based systems. 
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4. CONCLUSIONS 
In this study, single nucleotide polymorphism (SNP) detection was investigated 
through the use of two different sensor platforms (SPR and QCM) based on label free 
technology using commercially available oligonucleotides. The main aim of the study 
was to demonstrate the importance of biosensor technologies for diagnosis of 
molecular biomarkers for cancer through the detection of one-point mutations that 
occurs mostly in various region of p53 gene. A highly specific and sensitive 
hybridization reaction was successfully achieved in the concentration range of 0.03-2 
µM detection probe through a rapid, real-time assay approach. Furthermore, one-
point mutation could be significantly detected using interactions between target 
surface probes and detection probe by the Biacore 3000 and QCMA-1 instruments. 
When the reproducibility and effectiveness of the two developed assays on the 
sensors were compared, the SPR-based assay gave better results than the QCM-
based assay using the format applied in this study, though the obtained results from 
both platforms showed high similarity. Since the capture of target sequences on the 
sensor chip surface was stronger in the Biacore 3000 than the QCMA-1, the obtained 
hybridization responses gave parallel results. The performed experimental procedure 
was neither time-consuming nor with labelling; therefore, the achieved results 
indicate that both sensors  can be used for future application in  the diagnosis of a 
wide range of diseases which have gene marker in body fluids or tissue samples as 
an important alternative to the current used methods. 
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List of Figures 
Figure 1: Schematic representation of the applied experimental principle.  
Figure 2: Sensorgrams of NeutrAvidin immobilization (a) and capture of single-
stranded DNA sequences (scrambled sequence: grey line, wild-type target sequence: 
blue line, mutant-type target sequence: red line) using the Biacore 3000 system (b). 
Overall binding results of surface sequences to NeutrAvidin immobilized sensor 
surfaces (c). Bare-gold sensor chips were coated with 1% MUDA to obtain a self 
assembled monolayer prior to the immobilization of NeutrAvidin. The biotinylated 
target and control (scrambled) sequences were captured by NeutrAvidin immobilised 
surface via the specific interaction between the NeutrAvidin and biotin. 
Figure 3: Sensorgram of DNA hybridization using the Biacore 3000 instrument. The 
red line represents perfect match between mutant-type target surface and detection 
probe whilst the blue line shows one-point mismatch between wild-type target surface 
and detection probe. Gray line shows the non-specific binding on scrambled surface 
sequence (a). Overall results of DNA hybridization assay with confirmation of 
specificity and sensitivity (b). Linear regression and correlation coefficient of the 
results obtained in Biacore 3000 (c).  
Figure 4: Comparison of DNA capture (a) and hybridization results obtained from the 
different probe surfaces to detect one-point mutation using the QCMA-1 biosensor 
(b). Linear regression and correlation coefficient of the results in QCMA-1 instrument 
(c). Bare-gold QCM chips were coated with 100% MUDA to obtain a self assembled 
monolayer prior to the immobilization of NeutrAvidin on the surface. The biotinylated 
target and control (scrambled) sequences were captured by NeutrAvidin immobilised 
surface. The detection probe was designed according to the sequence of mutant-
type target and it shows a perfect match with mutated sequence whereas it has a 
mismatch on wild-type target because of one nucleotide change.  
Figure 5: Comparison of the two different sensor platforms for DNA capture (a) and 
hybridization assays (b). The used concentration of capture sequences (mutant-type 
target, wild-type target and scrambled control) were the same in both sensors (50 
µM). The hybridization efficiency of two sensors was compared for the reaction 
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between mutant-type target surface and detection probe in the concentration range 
of 0.03-2 µM. 
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